论文部分内容阅读
我院自1983年至1988年6月对46例Ⅲ期肺癌病人施行了全肺切除术,占同期肺癌手术数的21%。本文重点分析了治疗结果与影响预后的相关因素。1、3、5年生存率分别为67.4%、31.8%、14.2%。满意的效果说明全肺切除术仍是冶疗中晚期肺癌患者合理而行之有效的术式。着重讨论指出:严格掌握手术适应证;彻底清扫纵隔淋巴结;采用配合手术的综合治疗均是改善全肺切除术疗效、提高Ⅲ期肺癌病人生存期的有力措施。
In our hospital from 1983 to June 1988, 46 patients with stage III lung cancer underwent pneumonectomy, which accounted for 21% of lung cancer surgeries in the same period. This article focuses on analysis of treatment outcomes and related factors that influence prognosis. The 1-, 3-, and 5-year survival rates were 67.4%, 31.8%, and 14.2%, respectively. Satisfactory results show that pneumonectomy is still a reasonable and effective surgical treatment for patients with advanced lung cancer. The discussion focused on: Strict control of indications for surgery; complete removal of mediastinal lymph nodes; and use of comprehensive treatment combined with surgery are effective measures to improve the efficacy of pneumonectomy and improve the survival of patients with stage III lung cancer.